2021³â ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2021-03-13±³À°ÀÏÀÚ : 2021-03-13
±³À°Àå¼Ò : ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 1,2
±³À°ÁÖÁ¦ :
2021³â ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö±³À° ÁÖÃÖ±â°ü : ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ (ÀÌ»çÀåÁ¦)
´ã´çÀÚ : ¼Û¿¬Á¤
¿¬¶ôó : 070-4888-5731
À̸ÞÀÏ :
ksbtp.svc@gmail.com ±³À°Á¾·ù : Á¤½Å°Ç°ÀÇÇаú
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
±¤ÁÖ±¤¿ª½Ã±³À°½Ã°£ : 12 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 40,000¿ø
ºñ°í * »çÀüµî·Ï-Àü¹®ÀÇ 40,000¿ø/±ºÀü¹®ÀÇ,°øº¸ÀÇ,Àü°øÀÇ 20,000¿ø/°£È£»ç,ÀÓ»ó½É¸®»ç,»çȸº¹Áö»ç 20,000¿ø/Æò»ýȸ¿ø-¸éÁ¦ ** ÇöÀåµî·ÏÀº ¹ÞÁö ¾Ê½À´Ï´Ù.
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 1 09:40~10:05 COVID-19 From a Psychiatry Perspective: Meeting the Challenges ¼ºÇü¸ð(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 1 10:05~10:30 Telepsychiatry, Hospitals, and the COVID-19 Pandemic. È«Á¤¿Ï(Àͻ꺴¿ø)
±³À°½Ã°£ 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 1 10:30~10:55 Use of Telepsychiatry in Psychodynamic Psychiatry ±¸º»ÈÆ(¿µ³²ÀÇ´ë)
Åä·Ð 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 1 10:55~11:05 ÁúÀÇ ¹× Åä·Ð ()
±³À°½Ã°£ 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 1 11:15~11:40 The COVID-19 Global Pandemic: Implications for People with Schizophrenia and Related Disorders ±è¼º¿Ï(Àü³²ÀÇ´ë)
±³À°½Ã°£ 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 1 11:40~12:05 Clozapine and COVID-19 À̺´´ë(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 1 12:05~12:30 Long-acting injectable antipsychotics treatment during COVID-19 pandemic - A new challenge Àüµ¿¿í(ÀÎÁ¦ÀÇ´ë)
Åä·Ð 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 1 12:30~12:40 ÁúÀÇ ¹× Åä·Ð ()
±³À°½Ã°£ 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 1 12:40~13:40 How to diagnose and treat for better outcome in bipolar disorder ÃÖÅ¿µ(´ë±¸°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 1 13:40~14:05 Treatment resistant depression: A multi-scale, systems biology approach ÀÌÁ¤±¸(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 1 14:05~14:30 Management of Treatment-Resistant Depression: Challenges and Strategies Àå¼¼Çå(±è¿ø¹¬±â³äºÀ»ýº´¿ø)
±³À°½Ã°£ 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 1 14:30~14:55 Esketamine for treatment resistant depression ¹®Àº¼ö(ºÎ»êÀÇ´ë)
Åä·Ð 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 1 14:55~15:05 ÁúÀÇ ¹× Åä·Ð ()
±³À°½Ã°£ 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 1 15:15~15:40 The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of psychiatric illness Àå½ÂÈ£(¿ø±¤ÀÇ´ë)
±³À°½Ã°£ 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 1 15:40~16:05 Mitochondria a Promising Druggable Target for Alzheimer ÃßÀÏÇÑ(Á¶¼±ÀÇ´ë)
±³À°½Ã°£ 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 1 16:05~16:30 Orexin receptor antagonist for the treatment of insomnia ¹æ¿µ·Õ(µ¿¾ÆÀÇ´ë)
Åä·Ð 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 1 16:30~16:40 ÁúÀÇ ¹× Åä·Ð ()
±³À°½Ã°£ 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 2 09:30~09:40 Current and Future Issues in Psychiatry À̺´´ë(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 2 09:40~10:05 Signal processing for psychiatric condition ¹ÚÂù±â(KIST)
±³À°½Ã°£ 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 2 10:05~10:30 EEG microstate analysis and its application ±è°æ¿ø(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 2 10:30~10:55 Deep learning for psychiatric disorder ÀÌŽÄ(GIST)
Åä·Ð 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 2 10:55~11:05 ÁúÀÇ ¹× Åä·Ð ()
±³À°½Ã°£ 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 2 11:15~11:40 fNIRS in psychiatry ±èµµ¿ø(Àü³²´ëÀÇ°øÇаú)
±³À°½Ã°£ 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 2 11:40~12:05 Present and future of ultra-high field MRI ÀÌ»ó¿ø(°æºÏÀÇ´ë)
±³À°½Ã°£ 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 2 12:05~12:30 Cell-type-specific control in the brain by optogenetics and chemogenetics ±èÅÂ(GIST)
±³À°½Ã°£ 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 2 13:40~14:05 Neurobiology of anxiety À±Áö¾Ö(À»ÁöÀÇ´ë)
±³À°½Ã°£ 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 2 14:05~14:30 Stress evaluation and treatment strategy ¼È±Ô(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 2 14:30~14:55 Suicide Treatment Àü¹Î(Àü³²ÀÇ´ë)
Åä·Ð 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 2 14:55~15:05 ÁúÀÇ ¹× Åä·Ð ()
±³À°½Ã°£ 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 2 15:15~15:40 Neurobiology of childhood stress and trauma ¾çÂù¸ð(¿ø±¤ÀÇ´ë)
±³À°½Ã°£ 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 2 15:40~16:05 Initial assessment and management of child abuse ¹ÚÀçÈ«(µ¿¾ÆÀÇ´ë)
±³À°½Ã°£ 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 2 16:05~16:30 Healing Childhood Trauma Á¤¿î¼±(°æºÏÀÇ´ë)
Åä·Ð 03¿ù 13ÀÏ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 4Ãþ ´ëȸÀÇ½Ç 2 16:30~16:40 ÁúÀÇ ¹× Åä·Ð ()